David A. Schoenfeld

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better”.

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Molecular Cancer(2023)10.1186/s12943-023-01884-x

N/A

0.635DataRank · unranked

14 citations

Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi +18 more

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti–CTLA-4 in renal cell carcinoma

JCI Insight(2024)10.1172/jci.insight.184545

N/A

0.466DataRank · unranked

14 citations

Dijana Djureinovic, David Su, Lin Zhang, Benjamin Y. Lu, Larisa Kamga +8 more

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma

JCI Insight(2023)10.1172/jci.insight.157347

N/A

0DataRank · unranked

39 citations

Jasmine I. Caulfield, Lin Zhang, David A. Schoenfeld, Dijana Djureinovic, Veronica Chiang +6 more

Peripheral blood immune cell and cytokine profiling of patients receiving corticosteroids for immune checkpoint inhibitor-related adverse events: Steroid dose and duration.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14694

N/A

0DataRank · unranked

2 citations

David A. Schoenfeld, Dijana Djureinovic, Matthew Austin, Mamie Wang, Rihao Qu +8 more

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma

Research Square(2023)10.21203/rs.3.rs-3314825/v1

N/A

0DataRank · unranked

2 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007397

N/A

0DataRank · unranked

0 citations

David A. Schoenfeld, Jasmine I. Caulfield, Jacqueline E. Mann, Matthew R Austin, Ana Luisa Perdigoto +3 more

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma

JCO Precision Oncology(2024)10.1200/po.23.00702

N/A

0DataRank · unranked

12 citations

Dijana Djureinovic, David A. Schoenfeld, Bernadette Marquez‐Nostra, Kelly Olino, Lucia B. Jilaveanu +2 more

GP100 expression is variable in intensity in melanoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03776-5

N/A

0DataRank · unranked

10 citations

Nitzan Hasson, David Su, Adebowale Adeniran, Keiran S.M. Smalley, Dijana Djureinovic +4 more

TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03773-8

N/A

0DataRank · unranked

3 citations

Lucia B. Jilaveanu, Adebowale Adeniran, David Su, Michael E. Hurwitz, David A. Braun +3 more

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012358

N/A

0DataRank · unranked

4 citations

Noam Savion‐Gaiger, Ana Luisa Perdigoto, Jacqueline E. Mann, Madeline Candelas Torres, Genevieve M. Boland +12 more

Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-1039

N/A

0DataRank · unranked

20 citations

Royce Zhou, Sakellarios Zairis, William Su, Nicole Steinbach, Deepti Mathur +8 more

PRAME is not a frequently expressed antigen in renal cell carcinoma

BJUI Compass(2025)10.1002/bco2.70037

N/A

0DataRank · unranked

0 citations

Yael Derdikman Ofir, Jacqueline E. Mann, David Su, Tara Kim, Oscar Perales +5 more

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

Frontiers in Oncology(2022)10.3389/fonc.2022.990367

N/A

0DataRank · unranked

20 citations

Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar +5 more